• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在一项全国范围内的传播和实施研究中,对精神分裂症和重度抑郁症治疗指南的理解程度有所提高。

Improvements in the degree of understanding the treatment guidelines for schizophrenia and major depressive disorder in a nationwide dissemination and implementation study.

机构信息

Department of Psychiatry, Institute of Biomedical Science, Tokushima University Graduate School, Tokushima, Japan.

Department of Pathology of Mental Diseases, National Center of Neurology and Psychiatry, National Institute of Mental Health, Tokyo, Japan.

出版信息

Neuropsychopharmacol Rep. 2021 Jun;41(2):199-206. doi: 10.1002/npr2.12173. Epub 2021 Mar 11.

DOI:10.1002/npr2.12173
PMID:33704931
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8340832/
Abstract

BACKGROUND

To implement clinical practice guidelines (CPGs), it is necessary for psychiatrists to deepen their understanding of the CPGs. The Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE) project is a nationwide dissemination and implementation study of two sets of CPGs for schizophrenia and major depressive disorder (MDD).

METHODS

A total of 413 psychiatrists (n = 212 in 2016; n = 201 in 2017) learned the two CPGs in the education program of the EGUIDE project, and clinical knowledge of these CPGs was evaluated at baseline and after the programs. To improve the correct answer rate for clinical knowledge after the programs, we revised the lecture materials associated with items that had a low correct answer rate in 2016 and used the revised lecture materials with the CPGs in 2017. The rates of correct answers after the programs between the 2016 and 2017 groups were compared.

RESULTS

The correct answer rate of one item on the schizophrenia CPG and one item on the MDD CPG tended to be improved (S-D5 and D-C6) and that of one on the MDD CPG was significantly improved (D-D3, P = 0.0008) in the 2017 group compared to those in the 2016 group.

CONCLUSIONS

We reported improvements in clinical knowledge of CPGs after the EGUIDE program in the 2017 group following revision of the lecture materials based on results from the 2016 group. These attempts to improve the degree of understanding of CPGs may facilitate the successful dissemination and implementation of psychiatric guidelines in everyday practice.

摘要

背景

为了实施临床实践指南(CPGs),精神科医生有必要加深对 CPGs 的理解。Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment(EGUIDE)项目是一项针对精神分裂症和重度抑郁症(MDD)两套 CPGs 的全国性传播和实施研究。

方法

共有 413 名精神科医生(2016 年 n=212;2017 年 n=201)参加了 EGUIDE 项目的教育计划学习这两套 CPGs,并在基线和项目后评估了这些 CPGs 的临床知识。为了提高项目后临床知识的正确答案率,我们修订了与 2016 年低正确率项目相关的讲座材料,并在 2017 年使用修订后的讲座材料和 CPGs。比较了 2016 年和 2017 年组项目后正确答案率。

结果

2017 年组中,一项关于精神分裂症 CPG 的项目和一项关于 MDD CPG 的项目的正确答案率(S-D5 和 D-C6)有所提高,而 MDD CPG 的一项项目的正确答案率(D-D3)显著提高(P=0.0008),与 2016 年组相比。

结论

我们报告了 EGUIDE 项目后,在 2017 年组中,根据 2016 年组的结果修订讲座材料后,CPGs 的临床知识有所提高。这些提高对 CPGs 理解程度的尝试可能有助于成功传播和实施日常实践中的精神科指南。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/706d/8340832/317f58a9ed54/NPR2-41-199-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/706d/8340832/ef48e6996281/NPR2-41-199-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/706d/8340832/317f58a9ed54/NPR2-41-199-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/706d/8340832/ef48e6996281/NPR2-41-199-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/706d/8340832/317f58a9ed54/NPR2-41-199-g002.jpg

相似文献

1
Improvements in the degree of understanding the treatment guidelines for schizophrenia and major depressive disorder in a nationwide dissemination and implementation study.在一项全国范围内的传播和实施研究中,对精神分裂症和重度抑郁症治疗指南的理解程度有所提高。
Neuropsychopharmacol Rep. 2021 Jun;41(2):199-206. doi: 10.1002/npr2.12173. Epub 2021 Mar 11.
2
Improvement of psychiatrists' clinical knowledge of the treatment guidelines for schizophrenia and major depressive disorders using the 'Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)' project: A nationwide dissemination, education, and evaluation study.使用“精神科治疗指南传播与教育有效性(EGUIDE)”项目提高精神科医生对精神分裂症和重度抑郁症治疗指南的临床知识:一项全国范围的传播、教育和评估研究。
Psychiatry Clin Neurosci. 2019 Oct;73(10):642-648. doi: 10.1111/pcn.12911. Epub 2019 Aug 22.
3
The effect of education regarding treatment guidelines for schizophrenia and major depressive disorders on psychiatrists' hypnotic medication prescribing behavior: a multicenter study.教育对精神分裂症和重度抑郁症治疗指南的影响以及对精神科医生催眠药物处方行为的影响:一项多中心研究。
BMC Psychiatry. 2024 May 29;24(1):399. doi: 10.1186/s12888-024-05816-x.
4
Subjective assessment of participants in education programs on clinical practice guidelines in the field of psychiatry.教育项目中参与者对精神病学临床实践指南的主观评估。
Neuropsychopharmacol Rep. 2022 Jun;42(2):221-225. doi: 10.1002/npr2.12245. Epub 2022 Mar 10.
5
A dissemination and education programme to improve the clinical behaviours of psychiatrists in accordance with treatment guidelines for schizophrenia and major depressive disorders: the Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE) project.一项旨在根据精神分裂症和重度抑郁症治疗指南改善精神科医生临床行为的传播与教育计划:精神科治疗传播与教育指南的有效性(EGUIDE)项目。
BJPsych Open. 2022 Apr 21;8(3):e83. doi: 10.1192/bjo.2022.44.
6
Effect of education regarding treatment guidelines for schizophrenia and depression on the treatment behavior of psychiatrists: A multicenter study.精神分裂症和抑郁症治疗指南相关教育对精神科医生治疗行为的影响:一项多中心研究。
Psychiatry Clin Neurosci. 2023 Oct;77(10):559-568. doi: 10.1111/pcn.13578. Epub 2023 Sep 8.
7
Satisfaction with web-based courses on clinical practice guidelines for psychiatrists: Findings from the "Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)" project.基于网络的精神科临床实践指南课程的满意度:“精神科治疗指南传播与教育效果(EGUIDE)”项目的研究结果。
Neuropsychopharmacol Rep. 2023 Mar;43(1):23-32. doi: 10.1002/npr2.12300. Epub 2022 Nov 28.
8
Characteristics of discharge prescriptions for patients with schizophrenia or major depressive disorder: Real-world evidence from the Effectiveness of Guidelines for Dissemination and Education (EGUIDE) psychiatric treatment project.精神分裂症或重度抑郁症患者出院处方的特点:来自推广和教育指南(EGUIDE)精神科治疗项目的真实世界证据。
Asian J Psychiatr. 2021 Sep;63:102744. doi: 10.1016/j.ajp.2021.102744. Epub 2021 Jul 15.
9
The characteristics of patients receiving psychotropic pro re nata medication at discharge for the treatment of schizophrenia and major depressive disorder: A nationwide survey from the EGUIDE project.接受精神科按需药物治疗出院的精神分裂症和重度抑郁症患者的特征:来自 EGUIDE 项目的全国性调查。
Asian J Psychiatr. 2022 Mar;69:103007. doi: 10.1016/j.ajp.2022.103007. Epub 2022 Jan 13.
10
Implementation of a clinical practice guideline for schizophrenia in a specialist mental health center: an observational study.在一家专业心理健康中心实施精神分裂症临床实践指南:一项观察性研究。
BMC Health Serv Res. 2016 Aug 11;16(a):372. doi: 10.1186/s12913-016-1618-9.

引用本文的文献

1
Cross-sectional analysis of pharmaceutical industry payments to authors of clinical practice guidelines for bipolar disorder and major depressive disorder in Japan.日本双相情感障碍和重度抑郁症临床实践指南作者的制药业支付的横断面分析。
BMJ Open. 2024 Jun 21;14(6):e086396. doi: 10.1136/bmjopen-2024-086396.
2
The effect of education regarding treatment guidelines for schizophrenia and major depressive disorders on psychiatrists' hypnotic medication prescribing behavior: a multicenter study.教育对精神分裂症和重度抑郁症治疗指南的影响以及对精神科医生催眠药物处方行为的影响:一项多中心研究。
BMC Psychiatry. 2024 May 29;24(1):399. doi: 10.1186/s12888-024-05816-x.
3

本文引用的文献

1
Japanese Society of Neuropsychopharmacology: "Guideline for Pharmacological Therapy of Schizophrenia".日本神经精神药理学学会:《精神分裂症药物治疗指南》
Neuropsychopharmacol Rep. 2021 Sep;41(3):266-324. doi: 10.1002/npr2.12193. Epub 2021 Aug 12.
2
Multifactorial barriers in the implementation of schizophrenia and psychosocial therapies guidelines: A quantitative study across different professions.精神分裂症和心理社会疗法指南实施中的多因素障碍:不同专业的定量研究。
Schizophr Res. 2021 Feb;228:425-434. doi: 10.1016/j.schres.2021.01.010. Epub 2021 Feb 6.
3
Prescription patterns in patients with schizophrenia in Japan: First-quality indicator data from the survey of "Effectiveness of Guidelines for Dissemination and Education in psychiatric treatment (EGUIDE)" project.
Effect of education regarding treatment guidelines for schizophrenia and depression on the treatment behavior of psychiatrists: A multicenter study.
精神分裂症和抑郁症治疗指南相关教育对精神科医生治疗行为的影响:一项多中心研究。
Psychiatry Clin Neurosci. 2023 Oct;77(10):559-568. doi: 10.1111/pcn.13578. Epub 2023 Sep 8.
4
Relationships Between Adherence to Guideline Recommendations for Pharmacological Therapy Among Clinicians and Psychotic Symptoms in Patients With Schizophrenia.临床医生对精神分裂症患者药物治疗指南建议的遵从度与患者精神病症状之间的关系。
Int J Neuropsychopharmacol. 2023 Aug 29;26(8):557-565. doi: 10.1093/ijnp/pyad037.
5
The characteristics of discharge prescriptions including pro re nata psychotropic medications for patients with schizophrenia and major depressive disorder from the survey of the "Effectiveness of guidelines for dissemination and education in psychiatric treatment (EGUIDE)" project.来自“精神治疗中指南传播与教育的有效性(EGUIDE)”项目调查的、针对精神分裂症和重度抑郁症患者按需使用精神药物的出院处方特征。
Ann Gen Psychiatry. 2022 Dec 26;21(1):52. doi: 10.1186/s12991-022-00429-8.
6
Development of an individual fitness score (IFS) based on the depression treatment guidelines of in the Japanese Society of Mood Disorders.基于日本心境障碍学会的抑郁治疗指南制定个体健康评分(IFS)。
Neuropsychopharmacol Rep. 2023 Mar;43(1):33-39. doi: 10.1002/npr2.12301. Epub 2022 Nov 16.
7
Development of individual fitness score for conformity of prescriptions to the "Guidelines For Pharmacological Therapy of Schizophrenia".制定个体适应性评分以规范处方与《精神分裂症药物治疗指南》的一致性。
Neuropsychopharmacol Rep. 2022 Dec;42(4):502-509. doi: 10.1002/npr2.12293. Epub 2022 Oct 18.
8
Clozapine Treatment Is Associated With Higher Prescription Rate of Antipsychotic Monotherapy and Lower Prescription Rate of Other Concomitant Psychotropics: A Real-World Nationwide Study.氯氮平治疗与抗精神病药单药治疗的处方率较高和其他伴随精神药物的处方率较低相关:一项真实世界的全国性研究。
Int J Neuropsychopharmacol. 2022 Oct 25;25(10):818-826. doi: 10.1093/ijnp/pyac036.
9
Prescription of Anticholinergic Drugs in Patients With Schizophrenia: Analysis of Antipsychotic Prescription Patterns and Hospital Characteristics.精神分裂症患者抗胆碱能药物的处方:抗精神病药物处方模式及医院特征分析
Front Psychiatry. 2022 May 17;13:823826. doi: 10.3389/fpsyt.2022.823826. eCollection 2022.
10
A dissemination and education programme to improve the clinical behaviours of psychiatrists in accordance with treatment guidelines for schizophrenia and major depressive disorders: the Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE) project.一项旨在根据精神分裂症和重度抑郁症治疗指南改善精神科医生临床行为的传播与教育计划:精神科治疗传播与教育指南的有效性(EGUIDE)项目。
BJPsych Open. 2022 Apr 21;8(3):e83. doi: 10.1192/bjo.2022.44.
日本精神分裂症患者的处方模式:来自“精神科治疗指南传播与教育有效性调查(EGUIDE)”项目的第一质量指标数据。
Neuropsychopharmacol Rep. 2020 Sep;40(3):281-286. doi: 10.1002/npr2.12122. Epub 2020 Jun 30.
4
Factors associated with high-dose antipsychotic prescriptions in outpatients with schizophrenia: An analysis of claims data from a Japanese prefecture.与精神分裂症门诊患者高剂量抗精神病药物处方相关的因素:来自日本一个县的理赔数据分析。
Neuropsychopharmacol Rep. 2020 Sep;40(3):224-231. doi: 10.1002/npr2.12109. Epub 2020 May 26.
5
National database study on the use of long-acting antipsychotic injections and hospital readmission proportions in patients with schizophrenia in Japan.日本全国数据库研究:长效抗精神病药物注射与精神分裂症患者住院再入院比例的相关性
Psychiatry Clin Neurosci. 2020 Mar;74(3):211-217. doi: 10.1111/pcn.12970. Epub 2020 Feb 3.
6
The effect of Clinical Practice Guidelines on prescribing practice in mental health: A systematic review.临床实践指南对精神卫生处方实践的影响:系统评价。
Psychiatry Res. 2020 Feb;284:112671. doi: 10.1016/j.psychres.2019.112671. Epub 2019 Nov 1.
7
Improvement of psychiatrists' clinical knowledge of the treatment guidelines for schizophrenia and major depressive disorders using the 'Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)' project: A nationwide dissemination, education, and evaluation study.使用“精神科治疗指南传播与教育有效性(EGUIDE)”项目提高精神科医生对精神分裂症和重度抑郁症治疗指南的临床知识:一项全国范围的传播、教育和评估研究。
Psychiatry Clin Neurosci. 2019 Oct;73(10):642-648. doi: 10.1111/pcn.12911. Epub 2019 Aug 22.
8
Polypharmacy and psychotropic drug loading in patients with schizophrenia in Asian countries: Fourth survey of Research on Asian Prescription Patterns on antipsychotics.亚洲国家精神分裂症患者的药物滥用和精神药物负荷:亚洲抗精神病药物处方模式研究第四次调查。
Psychiatry Clin Neurosci. 2018 Aug;72(8):572-579. doi: 10.1111/pcn.12676. Epub 2018 Jun 19.
9
Implementation of treatment guidelines for specialist mental health care.专科精神卫生保健治疗指南的实施
Cochrane Database Syst Rev. 2016 Dec 15;12(12):CD009780. doi: 10.1002/14651858.CD009780.pub3.
10
Barriers and Strategies in Guideline Implementation-A Scoping Review.指南实施中的障碍与策略——一项范围综述
Healthcare (Basel). 2016 Jun 29;4(3):36. doi: 10.3390/healthcare4030036.